Literature DB >> 15271799

G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch.

Francesca Paglialunga1, Annalisa Fico, Ingram Iaccarino, Rosario Notaro, Lucio Luzzatto, Giuseppe Martini, Stefania Filosa.   

Abstract

Glucose 6-phosphate dehydrogenase (G6PD) (EC 1.1.1.42) is an essential enzyme for the rapid production of NADPH, as required on exposure to oxidative stress. Mouse embryonic stem (ES) cells can produce all embryonic and fetal/adult cell types. By studying the in vitro differentiation of embryoid bodies produced from G6pdDelta ES cells that are totally unable to produce G6PD protein, we found that these cells are able to differentiate into mesodermal cells, cardiomyocytes, hepatocytes, and primitive erythroid cells. However, we show here that, after the hemoglobin switch has taken place, definitive erythrocytes die by apoptosis. This apoptotic death is delayed by reducing agents and by a caspase inhibitor, but it is prevented only by the restoration of G6PD activity. Thus, G6PD proves indispensable for definitive erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271799     DOI: 10.1182/blood-2004-03-0835

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.

Authors:  Mehdi Nouraie; Noel S Reading; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

Review 2.  HTS/HCS to screen molecules able to maintain embryonic stem cell self-renewal or to induce differentiation: overview of protocols.

Authors:  Genesia Manganelli; Ugo Masullo; Stefania Filosa
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

3.  Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Françoise Lelong; Ralph Epaud; Corinne Pondarré; Serge Pissard
Journal:  Blood Adv       Date:  2018-03-27

4.  Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment.

Authors:  Shuhong Guo; Minoru Miyake; Ke Jian Liu; Honglian Shi
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

Review 5.  Mitochondria Turnover and Lysosomal Function in Hematopoietic Stem Cell Metabolism.

Authors:  Makiko Mochizuki-Kashio; Hiroko Shiozaki; Toshio Suda; Ayako Nakamura-Ishizu
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

6.  Modulation of the pentose phosphate pathway induces endodermal differentiation in embryonic stem cells.

Authors:  Genesia Manganelli; Annalisa Fico; Ugo Masullo; Fabiana Pizzolongo; Amelia Cimmino; Stefania Filosa
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

7.  Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolism.

Authors:  Tzu-Ling Chen; Hung-Chi Yang; Cheng-Yu Hung; Meng-Hsin Ou; Yi-Yun Pan; Mei-Ling Cheng; Arnold Stern; Szecheng J Lo; Daniel Tsun-Yee Chiu
Journal:  Cell Death Dis       Date:  2017-01-12       Impact factor: 8.469

Review 8.  Oxidative stress in β-thalassaemia and sickle cell disease.

Authors:  S Voskou; M Aslan; P Fanis; M Phylactides; M Kleanthous
Journal:  Redox Biol       Date:  2015-08-01       Impact factor: 11.799

Review 9.  The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy.

Authors:  Eunae Sandra Cho; Yong Hoon Cha; Hyun Sil Kim; Nam Hee Kim; Jong In Yook
Journal:  Biomol Ther (Seoul)       Date:  2018-01-01       Impact factor: 4.634

10.  A novel bone marrow-sparing treatment for primary erythrocytosis in a cat: Onion powder.

Authors:  Demitria M Vasilatis; Jennifer E McGill; Chen Gilor
Journal:  J Vet Intern Med       Date:  2021-06-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.